206 related articles for article (PubMed ID: 26300063)
61. MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil.
Fukushima T; Yoshio N; Noto Y; Kida H
Int J Hematol; 2002 Feb; 75(2):178-81. PubMed ID: 11939265
[TBL] [Abstract][Full Text] [Related]
62. [A case of t(3;3)(q21;q26.2) associated with severe multilineage dysplasia and multi-drug resistance in blastic crisis of chronic myelogenous leukemia].
Lee SA; Lim J; Kim M; Kim Y; Han K
Korean J Lab Med; 2010 Dec; 30(6):595-9. PubMed ID: 21157145
[TBL] [Abstract][Full Text] [Related]
63. Biallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemia.
Yamamoto K; Yakushijin K; Funakoshi Y; Inui Y; Okamura A; Matsuoka H; Minami H
Leuk Res; 2011 Nov; 35(11):e212-4. PubMed ID: 21803420
[No Abstract] [Full Text] [Related]
64. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
Sun J; Konoplev SN; Wang X; Cui W; Chen SS; Medeiros LJ; Lin P
Mod Pathol; 2011 Mar; 24(3):384-9. PubMed ID: 21113141
[TBL] [Abstract][Full Text] [Related]
65. Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
Weisser M; Haferlach C; Haferlach T; Schnittger S
Leuk Lymphoma; 2007 Nov; 48(11):2145-51. PubMed ID: 17926191
[TBL] [Abstract][Full Text] [Related]
66. Cytogenomic characterization of double minute heterogeneity in therapy related acute myeloid leukemia.
Koduru P; Chen W; Haley B; Ho K; Oliver D; Wilson K
Cancer Genet; 2019 Oct; 238():69-75. PubMed ID: 31425928
[TBL] [Abstract][Full Text] [Related]
67. [Clinical analysis of myeloid neoplasms with t (3;21) (q26;q22)].
Li Y; Liu Q; Wang Z; Qin YZ; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Lai YY
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):195-199. PubMed ID: 30929385
[No Abstract] [Full Text] [Related]
68. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA
Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775
[TBL] [Abstract][Full Text] [Related]
69. A Rare Case of ETV6/MECOM Rearrangement in Therapy-Related Acute Myeloid Leukemia with t(3;12) and Monosomy 7.
Kim YJ; Yang JJ; Han Y; Kim S; Yang HS; Yoon HJ; Lee JH; Lee WI; Park TS
Clin Lab; 2017 Feb; 63(2):415-418. PubMed ID: 28182364
[No Abstract] [Full Text] [Related]
70. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Owatari S; Otsuka M; Uozumi K; Takeshita T; Hanada S
Int J Hematol; 2007 Jan; 85(1):32-5. PubMed ID: 17261499
[TBL] [Abstract][Full Text] [Related]
71. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study.
Secker-Walker LM; Mehta A; Bain B
Br J Haematol; 1995 Oct; 91(2):490-501. PubMed ID: 8547101
[TBL] [Abstract][Full Text] [Related]
72. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia.
Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
Int J Hematol; 2003 Jun; 77(5):518-21. PubMed ID: 12841392
[TBL] [Abstract][Full Text] [Related]
73. Acute myelocytic leukemia associated with thrombocytosis and inv 3(q21.3; q26.2) in a case of Grönbland-Strandberg syndrome.
Tasaka T; Nagai M; Kubota Y; Sasaki K; Murata M; Taoka T; Ikeda K; Tanaka T; Takahara J; Irino S
Leuk Res; 1992 Dec; 16(12):1187-90. PubMed ID: 1465027
[TBL] [Abstract][Full Text] [Related]
74. Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma.
Kaplan SS; Rybka WB; Blom J; Shekhter-Levin S
Leuk Lymphoma; 1998 Nov; 31(5-6):617-23. PubMed ID: 9922054
[TBL] [Abstract][Full Text] [Related]
75. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26).
Reiter E; Greinix H; Rabitsch W; Keil F; Schwarzinger I; Jaeger U; Lechner K; Worel N; Streubel B; Fonatsch C; Mitterbauer G; Kalhs P
Ann Hematol; 2000 Jul; 79(7):374-7. PubMed ID: 10965785
[TBL] [Abstract][Full Text] [Related]
76. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
[TBL] [Abstract][Full Text] [Related]
77. Acute Myeloid Leukemia Diagnosed 5 Years after Adult T-Cell Leukemia/Lymphoma.
Owatari S; Arai A; Tsuruta T; Haraguchi K; Otsuka M; Hanada S
J Clin Exp Hematop; 2015; 55(1):29-31. PubMed ID: 26106004
[TBL] [Abstract][Full Text] [Related]
78. Therapy-related acute myeloid leukemia following HIV-associated lymphoma.
Mani D; Dorer RK; Aboulafia DM
Clin Lymphoma Myeloma; 2009 Aug; 9(4):316-9. PubMed ID: 19717383
[TBL] [Abstract][Full Text] [Related]
79. A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Izumi K; Akasaka T; Honjo G; Haga H
Leuk Lymphoma; 2019 Mar; 60(3):825-828. PubMed ID: 30187810
[No Abstract] [Full Text] [Related]
80. c-myc amplification in a preleukemia patient with trisomy 4 and double minutes: review of the unique coexistence of these two chromosome abnormalities in acute myelogenous leukemia.
Reddy KS; Sulcova V
Cancer Genet Cytogenet; 1997 Jun; 95(2):206-9. PubMed ID: 9169042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
